Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,176 | 147 | 96.6% |
| Education | $113.10 | 3 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $549.27 | 27 | $0 (2024) |
| Lilly USA, LLC | $319.83 | 15 | $0 (2024) |
| Abbott Laboratories | $308.75 | 14 | $0 (2024) |
| Dexcom, Inc. | $226.37 | 12 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $222.56 | 10 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $212.47 | 9 | $0 (2024) |
| Medtronic, Inc. | $169.53 | 5 | $0 (2024) |
| Amgen Inc. | $154.15 | 8 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $120.33 | 2 | $0 (2024) |
| Medtronic MiniMed, Inc. | $113.38 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,052 | 48 | Amneal Pharmaceuticals LLC ($186.58) |
| 2023 | $812.94 | 39 | Novo Nordisk Inc ($208.63) |
| 2022 | $461.69 | 22 | Novo Nordisk Inc ($102.85) |
| 2021 | $38.66 | 2 | Novo Nordisk Inc ($23.28) |
| 2020 | $152.73 | 4 | Tandem Diabetes Care, Inc. ($99.30) |
| 2019 | $37.91 | 2 | Sunovion Pharmaceuticals Inc. ($19.34) |
| 2018 | $258.32 | 11 | Medtronic MiniMed, Inc. ($113.38) |
| 2017 | $474.60 | 22 | Abbott Laboratories ($127.42) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Bone Health | ||||||
| 11/26/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $19.21 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/19/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Neuromodulation | ||||||
| 11/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $54.74 | General |
| Category: Durable Pump | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Endocrinology | ||||||
| 10/22/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Obesity | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Endocrinology | ||||||
| 09/17/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Bone Health | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes Care | ||||||
| 08/22/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Endocrinology | ||||||
| 07/31/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $22.83 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 580 | 1,944 | $435,797 | $88,653 |
| 2022 | 7 | 477 | 608 | $293,006 | $53,521 |
| 2021 | 9 | 466 | 1,406 | $319,937 | $64,010 |
| 2020 | 7 | 412 | 526 | $269,975 | $43,235 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 250 | 376 | $206,800 | $41,194 | 19.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 16 | 1,201 | $60,000 | $22,415 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $73,778 | $11,463 | 15.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 76 | $28,500 | $6,024 | 21.1% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 25 | 27 | $28,080 | $3,455 | 12.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 48 | 76 | $15,200 | $2,276 | 15.0% |
| 10006 | Fine needle aspiration biopsy using ultrasound guidance, each additional growth | Office | 2023 | 12 | 13 | $7,904 | $749.60 | 9.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 64 | 68 | $6,460 | $647.36 | 10.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 33 | $9,075 | $429.12 | 4.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 238 | 338 | $185,900 | $36,643 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $42,871 | $6,678 | 15.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 73 | $27,375 | $5,805 | 21.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 44 | 60 | $12,000 | $1,889 | 15.7% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 13 | 14 | $14,560 | $1,684 | 11.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 60 | 65 | $6,175 | $615.22 | 10.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 15 | $4,125 | $206.64 | 5.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 192 | 269 | $147,950 | $29,688 | 20.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 11 | 840 | $42,000 | $13,903 | 33.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 57 | 57 | $55,947 | $8,258 | 14.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 87 | $32,625 | $6,580 | 20.2% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 13 | 14 | $14,560 | $1,909 | 13.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $7,840 | $1,471 | 18.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 30 | 44 | $8,800 | $1,373 | 15.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 57 | 67 | $6,365 | $635.25 | 10.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 14 | $3,850 | $191.66 | 5.0% |
About Dr. Deepa Aravind, M.D
Dr. Deepa Aravind, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Smithtown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669677332.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepa Aravind, M.D has received a total of $3,289 in payments from pharmaceutical and medical device companies, with $1,052 received in 2024. These payments were reported across 150 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,176).
As a Medicare-enrolled provider, Aravind has provided services to 1,935 Medicare beneficiaries, totaling 4,484 services with total Medicare billing of $249,418. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Smithtown, NY
- Active Since 06/20/2007
- Last Updated 02/19/2021
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1669677332
Products in Payments
- UNITHROID (Drug) $212.47
- Dexcom G6 Transmitter (Medical Supply) $176.87
- Wegovy (Drug) $148.85
- Ozempic (Drug) $145.92
- EVENITY (Biological) $135.51
- MOUNJARO (Drug) $124.03
- Minimed 670G System (Device) $113.38
- FREESTYLE LIBRE 3 (Device) $112.03
- GVOKE HYPOPEN (Drug) $110.52
- FARXIGA (Drug) $102.58
- t:slim X2 insulin pump (Device) $99.30
- INVOKANA (Drug) $96.88
- FreeStyle Lite system (Device) $93.20
- MINIMED 780G (Device) $91.37
- Omnipod (Device) $87.38
- Rybelsus (Drug) $77.14
- RECORLEV (Drug) $63.73
- Senza (Device) $62.86
- JARDIANCE (Drug) $62.54
- Hillrom - Life 2000 Ventilation System (Device) $58.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Smithtown
Dr. Michael Shanik, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.3M
Mr. David Kugler, D.o, D.O
Endocrinology, Diabetes & Metabolism — Payments: $270,224
Sherry Sussman, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $116,564
Mrs. Niti Mohan, Pa, PA
Endocrinology, Diabetes & Metabolism — Payments: $8,416
Jessica Kramer, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,411